Citius Pharmaceuticals Inc (CTXR) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Citius Pharmaceuticals Inc   (NASDAQ: CTXR)


Citius Pharmaceuticals Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Citius Pharmaceuticals Inc's ROI in the third quarter of 2026?
Citius Pharmaceuticals Inc recorded a cumulative net loss of $-59 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -62.37%.

Within the Healthcare sector 522 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3685 to 3797.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Investment Change TTM 1.29 % 9.14 % 4.65 % 1.56 % -1.42 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 100 85 96 96 111
Return On Investment (TTM) -62.37 % -57.86 % -39.03 % -40.42 % -43.21 %
CTXR's Overall Ranking # 3797 # 3685 # 2936 # 3429 #
Seq. Investment Change TTM -2.75 % 1.77 % 1.16 % 1.17 % 4.79 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -59 -56 -37 -38 -40

CTXR Company Profile >> Back to CTXR Roi Comparisons >> See Annual CTXR Return On Investment



Return On Investment CTXR's Ranking
Within: No.
Industry # 227
Sector # 523
Overall # 3797

Return On Investment Statistics
High Average Low
-17.43 %
-48.54 %
-81.58 %
(Dec 31 2021)   (Mar 31 2016)







Financial Statements
Citius Pharmaceuticals Inc's III. Quarter Investments $ 100 Millions CTXR's Balance sheet
Citius Pharmaceuticals Inc's III. Quarter Income $ -12 Millions Quarterly CTXR's Income Statement
CTXR's Income by Division See CTXR's Income by Division


CTXR Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021
Total Investments in Millions 96 92 98 110 139
Y / Y Investment Growth 4.76 % -6.9 % -10.57 % -20.84 % 250.45 %
Net Income in Millions -40 -39 -34 -34 -23
Y / Y Net Income Growth - - - - -
Annual Return On Investment -41.4 % -43.02 % -34.23 % -30.56 % -16.58 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CTXR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CTXR's Competitors
Subscribers only: Roi for Citius Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for CTXR's Customers

Other Ratios
CTXR's Roa CTXR's Inventory Turnover Ratio CTXR's Growth Rates CTXR's Dividend Statistics
CTXR's Profitability Ratios CTXR's Asset Turnover Ratio CTXR's Dividend Growth
CTXR's Roe CTXR's Valuation Ratios CTXR's Financial Strength Ratios CTXR's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-12T06:21:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.